BioMarin Pharmaceuticals BMRN Price / earnings
Price / earnings at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's price / earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's price / earnings?
- BioMarin Pharmaceuticals (BMRN) reported price / earnings of 20× in Q3 2025.
- How has BioMarin Pharmaceuticals's price / earnings changed year-over-year?
- BioMarin Pharmaceuticals's price / earnings decreased by 51.9% year-over-year, from 41.5× to 20×.
- What is the long-term trend for BioMarin Pharmaceuticals's price / earnings?
- Over 3 years (2020 to 2024), BioMarin Pharmaceuticals's price / earnings has grown at a 15.9% compound annual growth rate (CAGR), from 18.9× to 29.3×.
- What does price / earnings mean?
- How many dollars investors pay for each dollar of the company's annual profit.
- How do you interpret price / earnings?
- Lower can mean cheaper — or that the market expects earnings to fall. High multiples embed growth expectations. Meaningless when earnings are negative, so it is suppressed there.
- How does price / earnings compare across companies?
- Compare against the company's own history and sector peers, not across sectors with different growth and risk profiles.